Brief: Imagion Biosystems Posts FY Net Loss Attributable A$9.3 Million
28/02/2023 24:57
Feb 28 (Reuters) - Imagion Biosystems Ltd IBX.AX :
* FY NET LOSS ATTRIBUTABLE A$9.3 MILLION
* FY REVENUE UP 7.5% TO A$3.1 MILLION
Source text for Eikon: ID:nASX6cPHVg
Further company coverage: IBX.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Imagion Biosystems
See all newsBrief: Imagion Biosystems Resumes Magsense Nanoparticle Manufacturing Capabilities
Brief: Imagion Biosystems Secures AU$3.75M In Capital Raise Following FDA Clearance Of Phase 2 Clinical Trial
Brief: Imagion Biosystems Secures A$3.75 Million In Firm Commitments Under Capital Raising
Australia's Imagion Biosystems falls on discounted placement
Brief: Imagion Biosystems Seeks Trading Halt